Navigation Links
USAID Airlifts Shelter Materials to Pakistan Quake Victims
Date:11/6/2008

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- The U.S. government, through the U.S. Agency for International Development, (USAID) airlifted plastic sheeting used to construct transitional shelters for families affected by the October 29 earthquake in Balochistan Province, Pakistan, to the provincial capital of Quetta. This USAID plastic sheeting will help meet the needs of approximately 13,000 people in the affected area as they face the upcoming winter.

USAID airlifted this plastic sheeting in direct response to an immediate need for emergency shelter identified by the USAID Disaster Assistance Response Team (USAID/DART) in coordination with local officials and the international relief community. The commodities, valued at more than $258,000 including transport costs, are included in the $2.5 million USAID has provided for the earthquake relief effort in Pakistan to date.

Through its international and non-governmental partners, USAID continues to distribute much-needed relief commodities in Balochistan Province. On November 3, the first trucks transporting USAID-funded plastic sheeting for the construction of temporary shelters arrived in Quetta. This plastic sheeting was distributed to affected villages in Ziarat District.

This emergency assistance from USAID is in addition to the more than $2 billion the U.S. has provided for development programs in Pakistan to improve health, education, economic growth, democratic governance and to reconstruct areas affected by the October 2005 earthquake.

For more information about USAID's emergency humanitarian assistance programs, please visit: http://www.usaid.gov/our_work/humanitarian_assistance/disaster_assistance.

The American people, through the U.S. Agency for International Development, have provided economic and humanitarian assistance worldwide for nearly 50 years

CONTA
'/>"/>

SOURCE U.S. Agency for International Development
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. USAID Provides Additional Wildfire Assistance to Greece
2. USAID Assistant Administrator Hess Travels to Southern Africa
3. New USAID grant helps Georgetown meet unmet family planning needs worldwide
4. USAID Announces First Malaria Communities Program Grants
5. USAID Sends Emergency Assistance to Djibouti for Cholera
6. From Kent Hill, USAID Assistant Administrator for Global Health on the Observance of International Day of Zero Tolerance
7. USAID Launches a $60 Million Child-Spacing and Reproductive-Health Program in Pakistan
8. USAID Awards $70 Million for the Prevention and Treatment of Obstetric Fistula
9. USAID Fights Neglected Tropical Diseases
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units
11. USAID Implements Behavior Change and Social Marketing Program in Rwanda
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 1Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 2Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 3Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 4Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 1Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 2Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 3Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 4Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 6Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 7Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 8Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 9Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 10Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 11Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 12Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 13Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 14Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 15Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 16Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 17Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 18Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 19Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 20Geneticists hunt for scleroderma triggers 60340 1Geneticists hunt for scleroderma triggers 60340 2